
Philipp Eibl, CTO & Christian Witz, CEO
Photo: Christine Rechling

SimVantage has succeeded in developing software that makes it possible to simulate and thus optimize aerated and/or stirred bioreactors. Bioreactors are required, for example, to produce modern medicines such as antibiotics, monoclonal antibodies for cancer therapy, or vector vaccines. In addition, they can also be used to produce Clean Meat, Food Additives or Precision Fermentation. With the findings from the software, the transition from the laboratory to production and thus the time to market maturity is significantly reduced. This helps companies to save time and money, which can subsequently also benefit the general public.
Inffeldgasse 13
8010 Graz / Austria
T: + 43 681 207 931 73
http://www.simvantage.com
Philipp Eibl, CTO & Christian Witz, CEO
Photo: Christine Rechling
Funded by
Member of
Powered by
Human.technology Styria GmbH
Neue Stiftingtalstrasse 2
Entrance B, 1st floor
8010 Graz, Austria
+43 316 58 70 16
office@humantechnology.at
Copyright Human.technology Styria GmbH / Design & Implementation: Koerbler GmbH